<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Activated T regulatory (T(reg)) cells are potent suppressors that mediate immune tolerance </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated the relationship between activated T(reg) cells and the progression of human <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We designed a cross-sectional study of CD4(+) Foxp3(+) T cells from peripheral blood, <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> and nontumor colon tissue of 42 patients with <z:hpo ids='HP_0003003'>colon cancer</z:hpo> and correlated the percentages of different subgroups of T(reg) cells with <z:hpo ids='HP_0003003'>colon cancer</z:hpo> stage </plain></SENT>
<SENT sid="3" pm="."><plain>The phenotypes, cytokine-release patterns and suppression ability of these T(reg) cells were analyzed </plain></SENT>
<SENT sid="4" pm="."><plain>We found that T(reg) cells increased significantly in both peripheral blood and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissue </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, the T(reg) cells expressed significantly lower levels of CCR7, CD62L and CD45RA in comparison to <z:mpath ids='MPATH_458'>normal</z:mpath> volunteers </plain></SENT>
<SENT sid="6" pm="."><plain>Further dividing T(reg) cells into subgroups based on Foxp3 and CD45RA expression revealed that both activated T(reg) cells (Foxp3(hi) CD45RA(-)) and nonsuppressive T(reg) cells (Foxp3(lo) CD45RA(-)), but not resting T(reg) cells (Foxp3(low) CD45RA(+)), increased in the peripheral blood and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissue of patients with <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Only the activated T(reg) cells expressed significantly higher levels of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor receptor 2 and cytotoxic T-cell antigen-4 </plain></SENT>
<SENT sid="8" pm="."><plain>Activated T(reg) cells, however, secreted significantly lower levels of effector cytokines (interleukin-2, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-α and interferon-γ) than did resting T(reg) cells and nonsuppressive cells upon ex vivo stimulation </plain></SENT>
<SENT sid="9" pm="."><plain>Activated, but not resting, T(reg) cells in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissue correlated with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>In summary, we confirmed that activated T(reg) cells are a distinct subgroup with effector memory phenotype and fully functional regulatory activity against human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> immunity </plain></SENT>
</text></document>